Anxiety, depression, sexual dysfunction and quality of life in prostate cancer based on stage of the disease

dc.contributor.authorKaya, Mehmet Cemal
dc.contributor.authorBez, Yasin
dc.contributor.authorDemir, Aslan
dc.contributor.authorBulut, Mahmut
dc.contributor.authorTopcuoglu, Volkan
dc.contributor.authorKuscu, Mehmet Kemal
dc.contributor.authorTurkeri, Niyazi Levent
dc.date.accessioned2024-04-24T17:27:40Z
dc.date.available2024-04-24T17:27:40Z
dc.date.issued2013
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground: Prostate cancer is common in men and in many studies quality of life, mental health problems and sexual dysfunction were examined in this population. However, there are relatively few studies examining the impact of the disease according to the stages. In this study we aimed to compare the levels of anxiety, depression, quality of life and sexual dysfunction of the prostate cancer patients according to their stages. Method: 80 patients with prostate cancer who applied to urology outpatient clinic were enrolled to the study. Patients were divided into three groups according to their stages; localized/organ-confined, local spread and metastatic spread. Short Form 36 (SF-36), Hospital Anxiety and Depression Scale (HAD) and the Arizona Sexual Experience Scale (ASEX) were performed. Results: According to the stage of prostate cancer, physical functioning subscale of quality of life was significantly lower in patients with metastatic prostate cancer than in patients with organ-confined prostate cancer (F=4.53, p=0.014). There were no associations between anxiety and depression scores and the stage of prostate cancer. Sexual desire was better in organ-confined prostate cancer patients compared to metastatic prostate cancer patients (F=5.32, p=0.007). Conclusion: The patients with prostate cancer might have different levels of physical functioning and sexual aversion problems at different stages of the disease. The clinicians should consider these two issues during follow-up of these patients.en_US
dc.identifier.doi10.5455/jmood.20130215041211
dc.identifier.endpage27en_US
dc.identifier.issn2146-1473
dc.identifier.issn2146-2380
dc.identifier.issue1en_US
dc.identifier.startpage23en_US
dc.identifier.urihttps://doi.org/10.5455/jmood.20130215041211
dc.identifier.urihttps://hdl.handle.net/11468/20125
dc.identifier.volume3en_US
dc.identifier.wosWOS:000421348200005
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isotren_US
dc.publisherYerkure Tanitim & Yayincilik Hizmetleri A Sen_US
dc.relation.ispartofJournal of Mood Disorders
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectProstate Canceren_US
dc.subjectAnxietyen_US
dc.subjectDepressionen_US
dc.subjectSexual Dysfunctionen_US
dc.subjectQuality Of Lifeen_US
dc.titleAnxiety, depression, sexual dysfunction and quality of life in prostate cancer based on stage of the diseaseen_US
dc.titleAnxiety, depression, sexual dysfunction and quality of life in prostate cancer based on stage of the disease
dc.typeArticleen_US

Dosyalar